Plexus (PLXS) to Release Earnings on Wednesday

Plexus (NASDAQ:PLXS) is projected to issue its Q4 2025 results after the market closes on Wednesday, October 22nd. Analysts expect the company to announce earnings of $1.84 per share and revenue of $1.0460 billion for the quarter. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS.Investors may visit the the company’s upcoming Q4 2025 earningresults page for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:30 AM ET.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.19. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 earnings per share. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Price Performance

Plexus stock opened at $148.52 on Monday. The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of 25.30 and a beta of 0.80. Plexus has a 52-week low of $103.43 and a 52-week high of $172.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. The stock’s 50 day moving average price is $139.44 and its two-hundred day moving average price is $132.88.

Analyst Upgrades and Downgrades

PLXS has been the topic of several research analyst reports. Wall Street Zen lowered shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Benchmark increased their price objective on shares of Plexus from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Monday, September 22nd. Stifel Nicolaus set a $140.00 target price on Plexus in a research report on Thursday, July 24th. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and increased their price target for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Plexus in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Plexus currently has a consensus rating of “Moderate Buy” and an average price target of $155.60.

Insider Buying and Selling at Plexus

In other Plexus news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $137.78, for a total transaction of $217,141.28. Following the completion of the sale, the chief accounting officer directly owned 24,495 shares of the company’s stock, valued at approximately $3,374,921.10. The trade was a 6.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the completion of the transaction, the chief financial officer owned 20,959 shares in the company, valued at $2,886,263.89. This represents a 10.66% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,856 shares of company stock worth $2,142,440. 1.76% of the stock is currently owned by corporate insiders.

Institutional Trading of Plexus

Several institutional investors have recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its position in shares of Plexus by 39.5% during the second quarter. BNP Paribas Financial Markets now owns 10,079 shares of the technology company’s stock valued at $1,364,000 after purchasing an additional 2,856 shares in the last quarter. Brevan Howard Capital Management LP purchased a new stake in Plexus in the 2nd quarter valued at about $1,356,000. Nebula Research & Development LLC lifted its position in shares of Plexus by 101.3% during the 2nd quarter. Nebula Research & Development LLC now owns 9,643 shares of the technology company’s stock worth $1,305,000 after buying an additional 4,853 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Plexus by 103.1% in the 1st quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after buying an additional 4,255 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Plexus by 1,526.7% in the second quarter. Tower Research Capital LLC TRC now owns 3,530 shares of the technology company’s stock valued at $478,000 after acquiring an additional 3,313 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.